• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性乳腺癌临床前模型中抗癌营养素和功能性食品的代谢靶点综述

A Review of Metabolic Targets of Anticancer Nutrients and Nutraceuticals in Pre-Clinical Models of Triple-Negative Breast Cancer.

机构信息

Department of Nutrition, University of North Carolina-Chapel Hill, Durham, NC 27599, USA.

Nutrition Research Institute, University of North Carolina-Chapel Hill, Kannapolis, NC 280821, USA.

出版信息

Nutrients. 2022 May 10;14(10):1990. doi: 10.3390/nu14101990.

DOI:10.3390/nu14101990
PMID:35631131
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9146055/
Abstract

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is notoriously aggressive and has poorer outcomes as compared with other breast cancer subtypes. Due to a lack of targeted therapies, TNBC is often treated with chemotherapeutics as opposed to hormone therapy or other targeted therapies available to individuals with estrogen receptor positive (ER+) breast cancers. Because of the lack of treatment options for TNBC, other therapeutic avenues are being explored. Metabolic reprogramming, a hallmark of cancer, provides potential opportunities to target cancer cells more specifically, increasing efficacy and reducing side effects. Nutrients serve a significant role in metabolic processes involved in DNA transcription, protein folding, and function as co-factors in enzyme activity, and may provide novel strategies to target cancer cell metabolism in TNBC. This article reviews studies that have investigated how nutrients/nutraceuticals target metabolic processes in TNBC cells alone or in combination with existing drugs to exert anticancer effects. These agents have been shown to cause perturbations in many metabolic processes related to glucose metabolism, fatty acid metabolism, as well as autophagy and oxidative stress-related metabolism. With this information, we present the potential of nutrients as metabolism-directed anticancer agents and the potential for using these agents alone or in cocktails as a new direction for TNBC therapy.

摘要

三阴性乳腺癌(TNBC)是一种乳腺癌亚型,与其他乳腺癌亚型相比,它具有侵袭性强、预后差的特点。由于缺乏靶向治疗药物,TNBC 通常采用化疗药物治疗,而不是针对雌激素受体阳性(ER+)乳腺癌患者的激素治疗或其他靶向治疗。由于缺乏 TNBC 的治疗选择,正在探索其他治疗途径。代谢重编程是癌症的一个标志,为更特异性地靶向癌细胞提供了潜在机会,提高了疗效,减少了副作用。营养素在参与 DNA 转录、蛋白质折叠和酶活性辅助因子的代谢过程中起着重要作用,可能为 TNBC 中的癌细胞代谢提供新的靶向策略。本文综述了研究如何单独或与现有药物联合使用营养素/营养保健品来发挥抗癌作用,以靶向 TNBC 细胞中的代谢过程。这些药物已被证明会导致与葡萄糖代谢、脂肪酸代谢以及自噬和氧化应激相关代谢有关的许多代谢过程发生紊乱。有了这些信息,我们提出了营养素作为代谢定向抗癌剂的潜力,以及单独或作为鸡尾酒使用这些药物作为 TNBC 治疗新方向的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30d/9146055/ad59c8eed3ef/nutrients-14-01990-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30d/9146055/ad59c8eed3ef/nutrients-14-01990-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30d/9146055/ad59c8eed3ef/nutrients-14-01990-g001.jpg

相似文献

1
A Review of Metabolic Targets of Anticancer Nutrients and Nutraceuticals in Pre-Clinical Models of Triple-Negative Breast Cancer.三阴性乳腺癌临床前模型中抗癌营养素和功能性食品的代谢靶点综述
Nutrients. 2022 May 10;14(10):1990. doi: 10.3390/nu14101990.
2
Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.毛蕊异黄酮通过下调新型雌激素受体-α剪接变体 ER-α30 介导的 PI3K/AKT 信号通路抑制三阴性乳腺癌的进展。
Phytomedicine. 2023 Sep;118:154924. doi: 10.1016/j.phymed.2023.154924. Epub 2023 Jun 14.
3
Mapping Novel Metabolic Nodes Targeted by Anti-Cancer Drugs that Impair Triple-Negative Breast Cancer Pathogenicity.绘制靶向削弱三阴性乳腺癌致病性的抗癌药物作用的新型代谢节点
ACS Chem Biol. 2017 Apr 21;12(4):1133-1140. doi: 10.1021/acschembio.6b01159. Epub 2017 Mar 8.
4
Metabolic reprogramming in triple-negative breast cancer.三阴性乳腺癌中的代谢重编程。
Cancer Biol Med. 2020 Feb 15;17(1):44-59. doi: 10.20892/j.issn.2095-3941.2019.0210.
5
Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction.三阴性乳腺癌对叶酸限制的代谢反应。
Nutrients. 2021 May 13;13(5):1637. doi: 10.3390/nu13051637.
6
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review.STAT3 作为三阴性乳腺癌潜在治疗靶点的系统评价。
J Exp Clin Cancer Res. 2019 May 14;38(1):195. doi: 10.1186/s13046-019-1206-z.
7
Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice.寡聚岩藻糖醛酸酯补充剂增强奥拉帕利对预防三阴性乳腺癌转移和复发的作用。
J Biomed Sci. 2022 Sep 15;29(1):70. doi: 10.1186/s12929-022-00855-6.
8
Novel combinatorial autophagy inhibition therapy for triple negative breast cancers.新型组合自噬抑制疗法治疗三阴性乳腺癌。
Eur J Pharmacol. 2024 Jun 15;973:176568. doi: 10.1016/j.ejphar.2024.176568. Epub 2024 Apr 9.
9
Metabolomics Analysis Reveals Novel Targets of Chemosensitizing Polyphenols and Omega-3 Polyunsaturated Fatty Acids in Triple Negative Breast Cancer Cells.代谢组学分析揭示了化学增敏多酚和ω-3 多不饱和脂肪酸在三阴性乳腺癌细胞中的新靶点。
Int J Mol Sci. 2023 Feb 23;24(5):4406. doi: 10.3390/ijms24054406.
10
Triple-negative breast cancer molecular subtyping and treatment progress.三阴性乳腺癌分子分型及治疗进展。
Breast Cancer Res. 2020 Jun 9;22(1):61. doi: 10.1186/s13058-020-01296-5.

引用本文的文献

1
Unraveling the immune evasion mechanisms in the tumor microenvironment of head and neck squamous cell carcinoma.解析头颈部鳞状细胞癌肿瘤微环境中的免疫逃逸机制。
Front Immunol. 2025 May 14;16:1597202. doi: 10.3389/fimmu.2025.1597202. eCollection 2025.
2
Development of silver-based hybrid nanoparticles loaded with eEF2 K-siRNA and quercetin against triple-negative breast cancer.负载真核翻译延伸因子2激酶小干扰RNA和槲皮素的银基杂化纳米颗粒用于三阴性乳腺癌的研究进展
Drug Deliv Transl Res. 2025 Apr 23. doi: 10.1007/s13346-025-01860-6.
3
Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomics.

本文引用的文献

1
Comparison of Lysis and Detachment Sample Preparation Methods for Cultured Triple-Negative Breast Cancer Cells Using UHPLC-HRMS-Based Metabolomics.基于超高效液相色谱-高分辨质谱代谢组学的培养三阴性乳腺癌细胞裂解和分离样品制备方法的比较
Metabolites. 2022 Feb 10;12(2):168. doi: 10.3390/metabo12020168.
2
Untargeted Metabolomics: Biochemical Perturbations in Golestan Cohort Study Opium Users Inform Intervention Strategies.非靶向代谢组学:戈勒斯坦队列研究中阿片类药物使用者的生化扰动为干预策略提供依据。
Front Nutr. 2020 Dec 22;7:584585. doi: 10.3389/fnut.2020.584585. eCollection 2020.
3
The apple dihydrochalcone phloretin suppresses growth and improves chemosensitivity of breast cancer cells via inhibition of cytoprotective autophagy.
探索代谢途径在三阴性乳腺癌免疫治疗中的作用:来自单细胞和空间转录组学的见解
Front Endocrinol (Lausanne). 2025 Jan 9;15:1528248. doi: 10.3389/fendo.2024.1528248. eCollection 2024.
4
Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer.巨噬细胞:对抗三阴性乳腺癌的关键角色。
Int J Mol Sci. 2024 Oct 7;25(19):10781. doi: 10.3390/ijms251910781.
5
Ferroptosis as a promising targeted therapy for triple negative breast cancer.铁死亡作为一种有前途的三阴性乳腺癌靶向治疗策略。
Breast Cancer Res Treat. 2024 Oct;207(3):497-513. doi: 10.1007/s10549-024-07387-7. Epub 2024 Jun 14.
6
n-3 PUFAs synergistically enhance the efficacy of doxorubicin by inhibiting the proliferation and invasion of breast cancer cells.n-3 多不饱和脂肪酸通过抑制乳腺癌细胞的增殖和侵袭协同增强阿霉素的疗效。
Med Oncol. 2023 Nov 28;41(1):2. doi: 10.1007/s12032-023-02229-w.
7
Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents.NCI-60 细胞系数据的多组学分析揭示了与烷基化抗癌药物耐药性相关的新型代谢过程。
Int J Mol Sci. 2023 Aug 26;24(17):13242. doi: 10.3390/ijms241713242.
8
Nutritional Metabolomics in Diet-Breast Cancer Relations: Current Research, Challenges, and Future Directions-A Review.饮食与乳腺癌关系中的营养代谢组学:当前研究、挑战及未来方向——综述
Biomedicines. 2023 Jun 27;11(7):1845. doi: 10.3390/biomedicines11071845.
9
Metabolomics Analysis Reveals Novel Targets of Chemosensitizing Polyphenols and Omega-3 Polyunsaturated Fatty Acids in Triple Negative Breast Cancer Cells.代谢组学分析揭示了化学增敏多酚和ω-3 多不饱和脂肪酸在三阴性乳腺癌细胞中的新靶点。
Int J Mol Sci. 2023 Feb 23;24(5):4406. doi: 10.3390/ijms24054406.
10
Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer.三阴性乳腺癌患者泛素化相关基因分类的鉴定及一种新型泛素化相关基因特征
Front Genet. 2023 Jan 6;13:932027. doi: 10.3389/fgene.2022.932027. eCollection 2022.
苹果二氢查尔酮根皮素通过抑制细胞保护性自噬来抑制乳腺癌细胞的生长并提高其化疗敏感性。
Food Funct. 2021 Jan 7;12(1):177-190. doi: 10.1039/d0fo02362k. Epub 2020 Dec 8.
4
St. John's Wort Suppresses Growth in Triple-Negative Breast Cancer Cell Line MDA-MB-231 by Inducing Prodeath Autophagy and Apoptosis.贯叶连翘通过诱导促死亡自噬和细胞凋亡抑制三阴性乳腺癌细胞系 MDA-MB-231 的生长。
Nutrients. 2020 Oct 17;12(10):3175. doi: 10.3390/nu12103175.
5
Molecular subtypes and precision treatment of triple-negative breast cancer.三阴性乳腺癌的分子亚型与精准治疗
Ann Transl Med. 2020 Apr;8(7):499. doi: 10.21037/atm.2020.03.194.
6
Metabolic Reprogramming in Triple-Negative Breast Cancer.三阴性乳腺癌中的代谢重编程
Front Oncol. 2020 Mar 31;10:428. doi: 10.3389/fonc.2020.00428. eCollection 2020.
7
Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies.三阴性乳腺癌:常规和先进治疗策略的综述。
Int J Environ Res Public Health. 2020 Mar 20;17(6):2078. doi: 10.3390/ijerph17062078.
8
Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models.膳食化合物异甘草素,一种来自甘草的抗氧化剂,通过在细胞和异种移植动物模型中激活凋亡死亡程序来抑制三阴性乳腺癌肿瘤生长。
Antioxidants (Basel). 2020 Mar 10;9(3):228. doi: 10.3390/antiox9030228.
9
Autophagy and autophagy-related proteins in cancer.癌症中的自噬和自噬相关蛋白。
Mol Cancer. 2020 Jan 22;19(1):12. doi: 10.1186/s12943-020-1138-4.
10
Regulation of Autophagy by mTOR Signaling Pathway.mTOR 信号通路对自噬的调控。
Adv Exp Med Biol. 2019;1206:67-83. doi: 10.1007/978-981-15-0602-4_3.